S.Amdt. 2796Senate115th Congress (2017-2019)2nd degree
S.Amdt. 2796
Sponsored by
Sen. John Kennedy (R-LA)
Submitted June 12, 2018
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
June 12, 2018
Text
Submitted
SA 2796. Mr. KENNEDY submitted an amendment intended to be proposed to amendment SA 2282 proposed by Mr. Inhofe (for himself and Mr. McCain) to the bill H.R. 5515, to authorize appropriations for fiscal year 2019 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes; which was ordered to lie on the table; as follows: At the end of subtitle I of title VIII, add the following: SEC. 896. COMMERCIALIZATION ASSISTANCE PILOT PROGRAM. Section 9 of the Small Business Act (15 U.S.C. 638) is amended by adding at the end the following: ``(tt) Commercialization Assistance Pilot Programs.-- ``(1) Pilot programs implemented.-- ``(A) In general.--Except as provided in subparagraph (B), not later than 1 year after the date of enactment of this subsection, a covered agency shall implement a commercialization assistance pilot program under which an eligible entity may receive a subsequent Phase II SBIR award. ``(B) Exception.--If the Administrator determines that a covered agency has a program that is sufficiently similar to the commercialization assistance pilot program established under this subsection, the covered agency shall not be required to implement a commercialization assistance pilot program under this subsection. ``(2) Percent of agency funds.--The head of each covered agency may allocate not more than 5 percent of the funds allocated to the SBIR program of the covered agency for the purpose of making a subsequent Phase II SBIR award under the commercialization assistance pilot program. ``(3) Termination.--A commercialization assistance pilot program established under this subsection shall terminate on September 30, 2022. ``(4) Application.--To be selected to receive a subsequent Phase II SBIR award under a commercialization assistance pilot program, an eligible entity shall submit to the covered agency implementing the pilot program an application at such time, in such manner, and containing such information as the covered agency may require, including-- ``(A) an updated Phase II commercialization plan; and ``(B) the source and amount of the matching funding required under paragraph (5). ``(5) Matching funding.-- ``(A) In general.--The Administrator shall require, as a condition of any subsequent Phase II SBIR award made to an eligible entity under this subsection, that a matching amount (excluding any fees collected by the eligible entity receiving the award) equal to the amount of the award be provided from an eligible third party investor. ``(B) Ineligible sources.--An eligible entity may not use funding from ineligible sources to meet the matching requirement of subparagraph (A). ``(C) Exception.--The Administrator shall not require, as a condition of any subsequent Phase II SBIR award made to an eligible entity under this subsection, a matching amount if the eligible entity is located in an underperforming State. ``(6) Award.--A subsequent Phase II SBIR award made to an eligible entity under this subsection-- ``(A) may not exceed the limitation described under subsection (aa)(1); and ``(B) shall be disbursed during Phase II. ``(7) Use of funds.--The funds awarded to an eligible entity under this subsection may only be used for research and development activities that build on Phase II program of the eligible entity's and ensure the research funded under that Phase II is rapidly progressing towards commercialization. ``(8) Selection.--In selecting eligible entities to participate in a commercialization assistance pilot program under this subsection, the head of a covered agency shall consider-- ``(A) the extent to which the award could aid the eligible entity in commercializing the research funded under the Phase II program of the eligible entity; ``(B) whether the updated Phase II commercialization plan submitted under paragraph (4) provides a sound approach for establishing technical feasibility that could lead to commercialization of the research; ``(C) whether the proposed activities to be conducted under the updated Phase II commercialization plan further improve the likelihood that the research will provide societal benefits; ``(D) whether the small business concern has progressed satisfactorily in Phase II to justify receipt of a subsequent Phase II SBIR award; ``(E) the expectations of the eligible third party investor that provides matching funding under paragraph (5); and ``(F) the likelihood that the proposed activities to be conducted under the updated Phase II commercialization plan using matching funding provided by the eligible third party investor will lead to commercial and societal benefit. ``(9) Evaluation report.--Not later than 3 years after the date of enactment of this subsection, the Comptroller General of the United States shall submit to the Committee on Small Business and Entrepreneurship of the Senate and the Committee on Science, Space, and Technology and the Committee on Small Business of the House of Representatives a report including-- ``(A) a summary of the activities of commercialization assistance pilot programs carried out under this subsection; ``(B) a detailed compilation of results achieved by those commercialization assistance pilot programs, including the number of eligible entities that received awards under those programs; ``(C) the rate at which each eligible entity that received a subsequent Phase II SBIR award under this subsection commercialized research of the recipient; ``(D) the growth in employment and revenue of eligible entities that is attributable to participation in a commercialization assistance pilot program; ``(E) a comparison of commercialization success of eligible entities participating in a commercialization assistance pilot program with recipients of an additional Phase II SBIR award under subsection (ff); ``(F) demographic information, such as ethnicity and geographic location, of eligible entities participating in a commercialization assistance pilot program; ``(G) an accounting of the funds used at each covered agency that implements a commercialization assistance pilot program under this subsection; ``(H) the amount of matching funding provided by eligible third party investors, set forth separately by source of funding; ``(I) an analysis of the effectiveness of the commercialization assistance pilot program implemented by each covered agency; and ``(J) recommendations for improvements to the commercialization assistance pilot program. ``(10) Definitions.--For purposes of this subsection: ``(A) Covered agency.--The term `covered agency' means a Federal agency required to have an SBIR program. ``(B) Eligible entity.--The term `eligible entity' means a small business concern that has received a Phase II award under an SBIR program and an additional Phase II SBIR award under subsection (ff) from the covered agency to which the small business concern is applying for a subsequent Phase II SBIR award. ``(C) Eligible third party investor.--The term `eligible third party investor' means a small business concern other than an eligible entity, a venture capital firm, an individual investor, a non-SBIR Federal, State or local government, or any combination thereof. ``(D) Ineligible sources.--The term `ineligible sources' means the following: ``(i) The internal research and development funds of the eligible entity. ``(ii) Funding in forms other than cash, such as in-kind or other intangible assets. ``(iii) Funding from the owners of the eligible entity, or the family members or affiliates of those owners. ``(iv) Funding attained through loans or other forms of debt obligations. ``(E) Subsequent phase ii sbir award.--The term `subsequent Phase II SBIR award' means an award granted to an eligible entity under this subsection to carry out further commercialization activities for research conducted pursuant to an SBIR program. ``(F) Underperforming state.--The term `underperforming State' means any State [[Page S3776]] participating in the SBIR program that is in the bottom 50 percent of all States historically receiving SBIR program funding.''. ______